Heebeom Koo

Prof. Heebeom Koo

Department of Medical Lifescience, College of Medicine, The Catholic University of Korea, Seoul, South Korea
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2011 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
DLDong-Eun Lee
Dong-Eun Lee
Heebeom KooHeebeom Koo
Heebeom Koo
ISIn-Cheol Sun
In-Cheol Sun
JRJu Hee Ryu
Ju Hee Ryu
KKKwangmeyung Kim
Kwangmeyung Kim
IKIck Chan Kwon
Ick Chan Kwon
Nanomedicine is the biomedical application of nanoscale materials for diagnosis and therapy of disease. Recent advances in nanotechnology and biotechnology have contributed to the development of multifunctional nanoparticles as representative nanomedicine. They were initially developed to enable the target-specific delivery of imaging or therapeutic agents for biomedical applications. Due to their unique features including multifunctionality, large surface area, structural diversity, and long circulation time in blood compared to small molecules, nanoparticles have emerged as attractive preferences for optimized therapy through personalized medicine. Multimodal imaging and theragnosis are the cutting-edge technologies where the advantages of nanoparticles are maximized. Because each imaging modality has its pros and cons, the integration of several imaging agents with different properties into multifunctional nanoparticles allows precise and fast diagnosis of disease through synergetic multimodal imaging. Moreover, nanoparticles are not only used for molecular imaging but also applied to deliver therapeutic agents to the disease site in order to accomplish the simultaneous imaging and therapy called theragnosis. This tutorial review will highlight the recent advances in the development of multifunctional nanoparticles and their biomedical applications to multimodal imaging and theragnosis as nanomedicine.

8 May 2019 in Cancers
Verified
Journal Article
Open access
PDF file
JYJihye Yoo
Jihye Yoo
CPChanghee Park
Changhee Park
GYGawon Yi
Gawon Yi
DLDonghyun Lee
Donghyun Lee
Heebeom KooHeebeom Koo
Heebeom Koo
Targeting nanoparticle (NP) carriers to sites of disease is critical for their successful use as drug delivery systems. Along with optimization of physicochemical properties, researchers have focused on surface modification of NPs with biological ligands. Such ligands can bind specific receptors on the surface of target cells. Furthermore, biological ligands can facilitate uptake of modified NPs, which is referred to as ‘active targeting’ of NPs. In this review, we discuss recent applications of biological ligands including proteins, polysaccharides, aptamers, peptides, and small molecules for NP-mediated drug delivery. We prioritized studies that have demonstrated targeting in animals over in vitro studies. We expect that this review will assist biomedical researchers working with NPs for drug delivery and imaging.

28 August 2019 in Chemical Science
Verified
Journal Article
Open access
Eunha KimEunha Kim
Eunha Kim
Heebeom KooHeebeom Koo
Heebeom Koo
Copper-free click chemistry has resulted in a change of paradigm, showing that artificial chemical reactions can occur on cell surfaces, in cell cytosol, or within the body. It has emerged as a valuable tool in biomedical fields.

18 August 2011 in Accounts of Chemical Research
Verified
Journal Article
Closed access
Heebeom KooHeebeom Koo
Heebeom Koo
MHMyung Sook Huh
Myung Sook Huh
ISIn-Cheol Sun
In-Cheol Sun
SYSoon Hong Yuk
Soon Hong Yuk
KCKuiwon Choi
Kuiwon Choi
IKIck Chan Kwon
Ick Chan Kwon

1 October 2011 in Biomaterials
Verified
Journal Article
Closed access
Hyun-Jong ChoHyun-Jong Cho
Hyun-Jong Cho
HYHong Yeol Yoon
Hong Yeol Yoon
Heebeom KooHeebeom Koo
Heebeom Koo
SKSeung-Hak Ko
Seung-Hak Ko
JSJae-Seong Shim
Jae-Seong Shim
DKDae-Duk Kim
Dae-Duk Kim

18 October 2012 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
Heebeom KooHeebeom Koo
Heebeom Koo
SLSangmin Lee
Sangmin Lee
JNJin Hee Na
Jin Hee Na
SKSun Hwa Kim
Sun Hwa Kim
Sei Kwang HahnSei Kwang Hahn
Sei Kwang Hahn
KKKwangmeyung Kim
Kwangmeyung Kim